Immunovia AB (publ)

kr 0.04As of Sun 8 Nov 2026, 12:00 UTC
STO:IMMNOVHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (52.55%)
Div yield —
ROE —
Diagnostics & Research
Beta (5Y) 2.72
PE TTM —
TSR TTM (88.24%)
Mkt cap kr 25.16M
ROIC (435.74%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 0.0467
25.00%
(57.69%)
Hold 5|9|1|8|3
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
—
—
—
—
(6.41%)
(9.23%)
(1.52%)
(2.86%)
Revenuekr M
1.922
1.878
1.946
1.985
5.77%
(0.10%)
(1.85%)
2.13%
Peers (US$2.543M)
Cap (US$)
PE
16.27M
—
Capital
TTM
5Y
10Y
Leveragex
0.058
2.622
2.409
EBIT/Intx
0.531
0.132
0.134
Own earn%
20.66
(55.40)
(70.11)
Sh yield%
17.31
51.34
52.28
Owners
Insiders/Inst%
0.99
52.37
Short interest%
4.23
SBC / revenue%
2.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
17–21
$1 testx
—
Incr. ROIC%
3